Evidence map›Paper›PMID 32320279›Full record

ArticleAmerican journal of physiology. Lung cellular and molecular physiology2020

The importance of reporting house dust mite endotoxin abundance: impact on the lung transcriptome.

Christopher D Pascoe, Aruni Jha, Sujata Basu, Thomas Mahood, Amy Lee, Sam Hinshaw, Reza Falsafi, Robert E W Hancock, Neeloffer Mookherjee, Andrew J Halayko

Open access · bronzeAbstract read
In one paragraph

Article in American journal of physiology. Lung cellular and molecular physiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Production ofJournal of immunology research · 2023
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Systematic Characterization of the Group 2 House Dust Mite Allergen inFrontiers in cellular and infection microbiology · 2021
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Christopher D PascoeDepartment of Physiology and Pathophysiology, University of Manitoba, Winnipeg, Manitoba, Canada.ORCID 0000-0002-5229-9927
Aruni JhaDepartment of Physiology and Pathophysiology, University of Manitoba, Winnipeg, Manitoba, Canada.
Sujata BasuBiology of Breathing Group, Children's Hospital Research Institute of Manitoba, Winnipeg, Manitoba, Canada.
Thomas MahoodDepartment of Physiology and Pathophysiology, University of Manitoba, Winnipeg, Manitoba, Canada.
Amy LeeCentre for Microbial Diseases and Immunity Research, University of British Columbia, Vancouver, British Columbia, Canada.
Sam HinshawCentre for Microbial Diseases and Immunity Research, University of British Columbia, Vancouver, British Columbia, Canada.
Reza FalsafiCentre for Microbial Diseases and Immunity Research, University of British Columbia, Vancouver, British Columbia, Canada.
Robert E W HancockCentre for Microbial Diseases and Immunity Research, University of British Columbia, Vancouver, British Columbia, Canada.
Neeloffer MookherjeeManitoba Centre for Proteomics and Systems Biology, Department of Internal Medicine, Winnipeg, Manitoba, Canada.
Andrew J HalaykoDepartment of Physiology and Pathophysiology, University of Manitoba, Winnipeg, Manitoba, Canada.ORCID 0000-0002-7865-4552
Research Manitoba · CAUniversity of British Columbia · CA

Funding

Gouvernement du Canada | CIHR | Institute of Health Services and Policy Research (IHSPR) MOP 123319
6 · The paper itself

Abstract

The abundance of lipopolysaccharide (LPS) in house dust mite (HDM) preparations is broad and mirrors the variability seen in the homes of people with asthma. LPS in commercially available stocks ranges from 31 to 5,2000 endotoxin units. The influence of vastly different LPS loads on the mechanisms that define the immune and inflammatory phenotype of HDM-challenged mice has not been defined. This aim of the study was to understand the lung phenotype of mice challenged with HDM extract containing high or low levels of LPS. Female BALB/c mice were sensitized for 2 wk with commercial HDM extract containing either high (36,000 endotoxin units; HHDM) or low (615 endotoxin units; LHDM) levels of LPS. Lung phenotype was characterized by measuring lung function, total and differential cell counts, cytokine abundance, and the lung transcriptome by RNA-sequencing. LPS levels in HDM stocks used for preclinical asthma research in mice remain poorly reported. In 2019, only 14% of papers specified LPS concentration in HDM lots. Specific differences existed in airway responsiveness between mice challenged with HHDM or LHDM. HHDM- and LHDM-induced cytokine profiles of bronchial lavage were significantly different and the lung transcriptome was differentially enriched for genes involved in DNA damage repair or cilium movement, following HHDM or LHDM challenge, respectively. The abundance of LPS in commercially available HDM influences the phenotype of allergic airways inflammation in mice. Failure to report the level of LPS in HDM extracts used in animal models of airway disease will lead to inconsistency in reproducibility and reliability of published data.

Indexed as

AnimalsAsthmaDisease Models, AnimalEndotoxinsFemaleGene Regulatory NetworksLipopolysaccharidesLungMice, Inbred BALB CPneumoniaPyroglyphidaeTranscriptomeEndotoxinsLipopolysaccharidesasthmaendotoxinhouse dust mitelipopolysaccharidelungRNA-seq

Identifiers

PMID32320279
PMCPMC7347269
OpenAlexW3016762137

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.